These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 461508)

  • 1. Some methodological aspects on the statistical analysis of pharmaco-EEG data.
    Ferner U
    Pharmakopsychiatr Neuropsychopharmakol; 1979 Mar; 12(2):220-7. PubMed ID: 461508
    [No Abstract]   [Full Text] [Related]  

  • 2. Statistical problems in the analysis of comparative pharmaco-EEG trials.
    Abt K
    Pharmakopsychiatr Neuropsychopharmakol; 1979 Mar; 12(2):228-36. PubMed ID: 461509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progresses of statistical spectral analysis in pharmaco-electroencephalography.
    Etevenon P; Pidoux B
    Pharmakopsychiatr Neuropsychopharmakol; 1979 Jan; 12(1):102-10. PubMed ID: 217025
    [No Abstract]   [Full Text] [Related]  

  • 4. Classification and evaluation of the pharmacodynamics of psychotropic drugs by single-lead pharmaco-EEG, EEG mapping and tomography (LORETA).
    Saletu B; Anderer P; Saletu-Zyhlarz GM; Arnold O; Pascual-Marqui RD
    Methods Find Exp Clin Pharmacol; 2002; 24 Suppl C():97-120. PubMed ID: 12575493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HZI systems for EEG parametrization and classification of psychotropic drugs.
    Itil TM; Shapiro DM; Herrmann WM; Schulz W; Morgan V
    Pharmakopsychiatr Neuropsychopharmakol; 1979 Jan; 12(1):4-19. PubMed ID: 419164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Quantitative pharmaco-EEG study of nootropics].
    Kinoshita T
    Seishin Shinkeigaku Zasshi; 1990; 92(5):255-76. PubMed ID: 2119513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Planning of pharmacodynamic trials: I. Specificity and possible solutions. II. Stability considerations under placebo and interpretation of drug effects on EEG.
    Boeijinga PH; Calvi-Gries F; Demazières A; Luthringer R
    Methods Find Exp Clin Pharmacol; 2002; 24 Suppl C():17-26. PubMed ID: 12575484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Animal pharmaco-EEG: models, facts and fallacies.
    Ruigt GS
    Methods Find Exp Clin Pharmacol; 2002; 24 Suppl D():59-61. PubMed ID: 12575469
    [No Abstract]   [Full Text] [Related]  

  • 9. Guidelines for pharmaco-EEG studies in man. Expert group, organized of the Federal Health Office, Institute for Drugs, Berlin (West), Germany.
    Pharmacopsychiatria; 1982 May; 15(3):107-8. PubMed ID: 7048353
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmaco-EEG experiments in animals.
    Stumpf C
    Neuropsychobiology; 1984; 12(2-3):179-82. PubMed ID: 6396529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remembering the lost neuroscience of pharmaco-EEG.
    Fink M
    Acta Psychiatr Scand; 2010 Mar; 121(3):161-73. PubMed ID: 20148773
    [No Abstract]   [Full Text] [Related]  

  • 12. Correction for model selection bias using a modified model averaging approach for supervised learning methods applied to EEG experiments.
    Wouters K; Abrahantes JC; Molenberghs G; Geys H; Ahnaou A; Drinkenburg WH; Bijnens L
    J Biopharm Stat; 2010 Jul; 20(4):768-86. PubMed ID: 20496205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of psychoactivity and cerebral bioavailability of danitracene (WA 335) by quantitative pharmaco-EEG and psychometric investigations.
    Saletu B; Grünberger J; Flener R; Linzmayer L; Sieroslawski H
    Curr Ther Res Clin Exp; 1976 Dec; 20(6):810-21. PubMed ID: 827426
    [No Abstract]   [Full Text] [Related]  

  • 14. [A quantitative pharmaco-EEG study on psychotropic properties of cerebral metabolic enhancers: comparison between young and elderly healthy volunteers].
    Nobuhara K
    Seishin Shinkeigaku Zasshi; 1993; 95(5):392-416. PubMed ID: 8356168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of pharmacodynamic properties of psychotropic drugs: quanitative EEG, psychometric and blood level investigations in normals and patients.
    Saletu B; Grünberger J
    Pharmakopsychiatr Neuropsychopharmakol; 1979 Jan; 12(1):45-58. PubMed ID: 419165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vigilance and evaluation of psychotropic drug effects on EEG.
    Bente D
    Pharmakopsychiatr Neuropsychopharmakol; 1979 Mar; 12(2):137-47. PubMed ID: 461501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of clinical psychiatry in the development of new drugs].
    Benkert O; Hippius H
    Arzneimittelforschung; 1975 Jul; 25(7a):1195-206. PubMed ID: 1242348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmaco-EEG in psychiatry.
    Mucci A; Volpe U; Merlotti E; Bucci P; Galderisi S
    Clin EEG Neurosci; 2006 Apr; 37(2):81-98. PubMed ID: 16733940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the EEG in the study of psychological and psychopathological activity.
    Monakhov KK
    Hum Physiol; 1981; 7(5):327-37. PubMed ID: 7348219
    [No Abstract]   [Full Text] [Related]  

  • 20. Predictive value of pharmaco-electroencephalography in early human-pharmacological evaluations of psychoactive drugs. First example: savoxepine.
    Herrmann WM; Schärer E; Delini-Stula A
    Pharmacopsychiatry; 1991 Nov; 24(6):196-205. PubMed ID: 1687485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.